Green or yellow laser treatment for diabetic macular edema: Exploratory assessment within the diabetic retinopathy clinical research network

Retina

Volumn 33, Issue 10, 2013, Pages 2080-2088

  Bressler, Susan B ^a   Almukhtar, Talat ^b   Aiello, Lloyd P ^c   Bressler, Neil M ^a   Ferris, Frederick L ^d   Glassman, Adam R ^b   Greven, Craig M ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

ARTICLE; DIABETIC MACULAR EDEMA; HUMAN; LASER COAGULATION; OPHTHALMIC LASER; OPTICAL COHERENCE TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULOPATHY; SHAM PROCEDURE; SPECTRAL SENSITIVITY; THICKNESS; VISION; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; LASERS, DYE; MACULAR EDEMA; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84887088102     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318295f744     Document Type: Article

References (23)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985;103:1796-1806.
2. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.e35.
3. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-625.
4. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012;119:789-801.
5. Michaelides M, Kaines A, Hamilton RD, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 2010;117:1078-1086.e2.
6. Do DV, Schmidt-Erfurth U, Gonzalez VH, et al. The DA VINCI study: phase 2 primary results of VEGF trap-eye in patients with diabetic macular edema. Ophthalmology 2011; 118:1819-1826.
7. Olk RJ.Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93:938-950.
8. Figueira J, Khan J, Nunes S, et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 2009;93:1341-1344.
9. Kwasniewska FS. Lasers in Ophthalmology: Basic, Diagnostic, and Surgical Aspects. The Hague, The Netherlands: Kugler Publication; 2003: 175.
10. Price R, Jerome J. Basic Confocal Microscopy. New York, NY: Springer; 2011: 18.
11. Trempe CL, Mainster MA, Pomerantzeff O, et al. Macular photocoagulation. Optimal wavelength selection. Ophthalmology 1982;89:721-728.
12. SmiddyWE, Fine SL, Quigley HA, et al. Comparison of krypton and argon laser photocoagulation. Results of stimulated clinical treatment of primate retina. Arch Ophthalmol 1984;102: 1086-1092.
13. Smiddy WE, Fine SL, Green WR, et al. Clinicopathologic correlation of krypton red, argon blue-green, and argon green laser photocoagulation in the human fundus. Retina 1984;4:15-21.
14. Mainster MA. Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology 1986;93:952-958.
15. Lock JH, Fong KC. An update on retinal laser therapy. Clin Exp Optom 2011;94:43-51.
16. Thaung J, Sjostrand J. Integrated light scattering as a function of wavelength in donor lenses. J Opt Soc Am A Opt Image Sci Vis 2002;19:152-157.
17. Castillejos-Rios D, Devenyi R, Moffat K, et al. Dye yellow vs. argon green laser in panretinal photocoagulation for proliferative diabetic retinopathy: a comparison of minimum power requirements. Can J Ophthalmol 1992;27:243-244.
18. Riss JM. Retinal vascular closure using laser photocoagulation [French]. Chirurgie 1996;121:309-316.
19. Browning DJ, Antoszyk AN. The effect of the surgeon and the laser wavelength on the response to focal photocoagulation for diabetic macular edema. Ophthalmology 1999;106:243-248.
20. Karacorlu S, Burumcek E, Karacorlu M, et al. Treatment of diabetic macular edema: a comparison between argon and dye lasers. Ann Ophthalmol 1993;25:138-141.
21. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1449, 1449.e1-e10.
22. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 2003;135:194-205.
23. Blumenkranz MS, Yellachich D, Andersen DE, et al. Semiautomated patterned scanning laser for retinal photocoagulation. Retina 2006;26:370-376.